Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, D Miller C, Lim LL, Suhler EB, Al-Dhibi HA et al..  2025.  Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.. Ocul Immunol Inflamm. 33(2):263-270.

Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.

O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.

Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.

Doan T, Hinterwirth A, Worden L, Arzika AM, Maliki R, Chen C, Zhong L, Zhou Z, Acharya NR, Porco TC et al..  2020.  Post-antibiotic Ocular Surface Microbiome in Children: A Cluster-Randomized Trial.. Ophthalmology. 127(8):1127-1130.

Takhar JS, Joye AS, Somkijrungroj T, Laovirojjanakul W, Lin C-P, Lietman TM, Porco TC, Keenan JD, Gebreegziabher EA, Seitzman GD et al..  2019.  A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol.. BMJ Open. 9(12):e033175.

Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.

Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, S Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T et al..  2019.  Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.. JAMA. 322(10):936-945.

Ray KJ, Cotter SY, Arzika AM, Kim J, Boubacar N, Zhou Z, Zhong L, Porco TC, Keenan JD, Lietman TM et al..  2019.  High-throughput sequencing of pooled samples to determine community-level microbiome diversity.. Ann Epidemiol. 39:63-68.

Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.

Doan T, Arzika AM, Hinterwirth A, Maliki R, Zhong L, Cummings S, Sarkar S, Chen C, Porco TC, Keenan JD et al..  2019.  Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.. N Engl J Med. 380(23):2271-2273.

Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.

Doan T, Arzika AM, Ray KJ, Cotter SY, Kim J, Maliki R, Zhong L, Zhou Z, Porco TC, Vanderschelden B et al..  2017.  Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.. Clin Infect Dis. 64(9):1147-1153.